97 related articles for article (PubMed ID: 3488740)
1. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium on aromatic L-amino acid decarboxylase in rat brain.
Siow YL; Dakshinamurti K
Biochem Pharmacol; 1986 Aug; 35(15):2640-1. PubMed ID: 3488740
[No Abstract] [Full Text] [Related]
2. Changes in lipid peroxidation induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in mouse brain homogenates.
Ríos C; Tapia R
Neurosci Lett; 1987 Jun; 77(3):321-6. PubMed ID: 3497366
[TBL] [Abstract][Full Text] [Related]
3. Substituted phenylpiperidines and phenylpyridines as reversible selective inhibitors of monoamine oxidase type A in rodent brain and liver.
Kula NS; Baldessarini RJ; Murphy F; Neumeyer JL
Biochem Pharmacol; 1988 Feb; 37(4):763-6. PubMed ID: 3257699
[No Abstract] [Full Text] [Related]
4. Failure to detect 6-hydroxydopamine in rat striatum after the dopamine releasing drugs dexamphetamine, methylamphetamine and MPTP.
Rollema H; De Vries JB; Westerink BH; Van Putten FM; Horn AS
Eur J Pharmacol; 1986 Dec; 132(1):65-9. PubMed ID: 3102260
[TBL] [Abstract][Full Text] [Related]
5. Acute peripheral catecholaminergic changes in rat after MPTP and MPP+ treatment.
Ambrosio S; Mahy N
Rev Esp Fisiol; 1989 Jun; 45(2):157-61. PubMed ID: 2570448
[TBL] [Abstract][Full Text] [Related]
6. Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Singer TP; Salach JI; Crabtree D
Biochem Biophys Res Commun; 1985 Mar; 127(2):707-12. PubMed ID: 3872126
[TBL] [Abstract][Full Text] [Related]
7. Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Singer TP; Castagnoli N; Ramsay RR; Trevor AJ
J Neurochem; 1987 Jul; 49(1):1-8. PubMed ID: 3495634
[No Abstract] [Full Text] [Related]
8. The effects of pyridinium salts, structurally related compounds of 1-methyl-4-phenylpyridinium ion (MPP+), on tyrosine hydroxylation in rat striatal tissue slices.
Hirata Y; Sugimura H; Takei H; Nagatsu T
Brain Res; 1986 Nov; 397(2):341-4. PubMed ID: 3099974
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the tyrosine hydroxylase system by MPTP, 1-methyl-4-phenylpyridinium ion (MPP+) and the structurally related compounds in vitro and in vivo.
Nagatsu T; Hirata Y
Eur Neurol; 1987; 26 Suppl 1():11-5. PubMed ID: 2884110
[TBL] [Abstract][Full Text] [Related]
10. Central hypothermic effects of some analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium ion (MPP+).
Satoh N; Yonezawa A; Tadano T; Kisara K; Arai Y; Kinemuchi H
Neurosci Lett; 1987 Sep; 80(1):100-5. PubMed ID: 3498916
[TBL] [Abstract][Full Text] [Related]
11. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
12. Effect of pyridoxine deficiency on aromatic L-amino acid decarboxylase in adult rat brain.
Siow YL; Dakshinamurti K
Exp Brain Res; 1985; 59(3):575-81. PubMed ID: 3875501
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of aromatic L-aminoacid decarboxylase in clonal pheochromocytoma PC12h cells by N-methyl-4-phenylpyridinium ion (MPP+).
Naoi M; Takahashi T; Ichinose H; Nagatsu T
Biochem Biophys Res Commun; 1988 Apr; 152(1):15-21. PubMed ID: 3258744
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
Fuller RW; Hemrick-Luecke SK; Robertson DW
Biochem Pharmacol; 1988 Sep; 37(17):3343-7. PubMed ID: 3135812
[TBL] [Abstract][Full Text] [Related]
15. New and highly sensitive assay for L-5-hydroxytryptophan decarboxylase activity by high-performance liquid chromatography-voltammetry.
Rahman MK; Nagatsu T; Kato T
J Chromatogr; 1980 Dec; 221(2):265-70. PubMed ID: 6971297
[TBL] [Abstract][Full Text] [Related]
16. 1-Methyl-4-phenyl-pyridinium-induced inhibition of nicotinamide adenosine dinucleotide cytochrome c reductase.
Poirier J; Barbeau A
Neurosci Lett; 1985 Nov; 62(1):7-11. PubMed ID: 3877888
[TBL] [Abstract][Full Text] [Related]
17. Reduction of aromatic L-amino acid decarboxylase activity in clonal pheochromocytoma PC12h cells by culture in the presence of N-methyl-4-phenylpyridinium ion (MPP+).
Naoi M; Ichinose H; Takahashi T; Nagatsu I; Nagatsu T
Neurosci Lett; 1988 Dec; 95(1-3):229-35. PubMed ID: 3265769
[TBL] [Abstract][Full Text] [Related]
18. Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats.
Chang GD; Ramirez VD
Brain Res; 1987 Oct; 424(1):49-57. PubMed ID: 3319041
[TBL] [Abstract][Full Text] [Related]
19. High-performance liquid chromatographic procedure for the simultaneous determination of aromatic L-amino acid decarboxylase activity towards 3,4-dihydroxyphenylalanine and 5-hydroxytryptophan.
Zuo DM; Yu PH
J Chromatogr; 1991 Jul; 567(2):381-8. PubMed ID: 1939471
[TBL] [Abstract][Full Text] [Related]
20. Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain.
Riachi NJ; LaManna JC; Harik SI
J Pharmacol Exp Ther; 1989 Jun; 249(3):744-8. PubMed ID: 2786562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
